314 Both 14-Day Hybrid and Bismuth Containing Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With Moderate Antibiotic Resistance - A Randomized Controlled Trial

Hsu, Ping‐I; Wu, Deng‐Chyang; Tsay, Feng-Woei Tsay

doi:10.1016/s0016-5085(16)30360-2

314 Both 14-Day Hybrid and Bismuth Containing Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With Moderate Antibiotic Resistance - A Randomized Controlled Trial

Ping‐I Hsu, Deng‐Chyang Wu, Feng-Woei Tsay Tsay

Ping‐I Hsu

NobleIDNI7P53W52R36S66

Type:Journal Article

Claim Your Authorship

Sign in to see the full record

Creating an account is free.

Create an account

For data access, contact info@nobleid.org.

314 Both 14-Day Hybrid and Bismuth Containing Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With Moderate Antibiotic Resistance - A Randomized Controlled Trial | NobleID